CONNELL: SO REALLY SEEN AT THE
LIGHT AT THE END OF THE TUNNEL.
PFIZER AND BIONTECH ANNOUNCED
THE COVID-19 VACCINE CANDIDATES
MORE THAN 90% EFFECTIVE IN THE
SPREAD OF THE VIRUS.
IT COPS AS THE U.S. SURPASSES
10 MILLION CORONAVIRUS
INFECTIONS.
HERE WITH PERSPECTIVE HOW
IMPORTANT THIS ALL IS, IS
DR. NICOLE SAPHIER, FOX NEWS
CONTRIBUTOR.
THE 90% NUMBER, WHAT I HEARD
BEFOREHAND, PEOPLE WOULD BE
HAPPY WITH LESS THAN THAT, THAT
REALLY STAND AS IT.
THAT IS REALLY EFFECTIVE, 90%.
WHAT DOES IT ALL MEAN THOUGH?
>> THE PRELIMINARY DATA OUT OF
TENS OF THOUSANDS OF PATIENTS
COMING OUT OF PFIZER, IT SAYS IT
PREVENTS INFECTIONS FROM 90% OF
PEOPLE, TO GET FDA APPROVAL IT
NEEDED TO BE MORE THAN 350%.
THE FLU VACCINE RANGES FROM 30
TO 50% EFFECTIVE EVERY YEAR.
THIS IS MORE EFFECTIVE THAN THE
FLU VACCINE.
AS WE SEE DATA COME OUT AND THAT
90% MAY NOT STAY THE SAME.
IT MAY GET BETTER OR GET WORSE.
THE PRELIMINARY RESULTS IS GREAT
NEWS AND VERY ENCOURAGING FOR
THE PFIZER VACCINE, THE MRNA
VACCINE PROBABLY BODES WELL WITH
MODERNA WHO USE AS SIMILAR TYPE
OF VACCINE.
IT IS GREAT TO HOPEFULLY HEAR
ENCOURAGING RESULTS FROM MODERNA
AS WELL.
CONNELL: THE FACT PFIZER
ENCOURAGING THAT MODERNA IS
ENCOURAGING.
THAT IS INTERESTING.
THE IT IS TWO DOSE VACCINE, IF
YOU DO THE MATH, IT WOULD BE 28
DAYS BEFORE YOU HAVE THE WHOLE
FULL PROTECTION.
SHOULD WE READ ANYTHING INTO
THAT?
WHAT SHOULD WE TAKE AWAY FROM
THAT?
>> WELL TWO DOSES OR TWO
INOCULATIONS MEAN TWICE AS MUCH
SUPPLIES ARE NEEDED.
TWO SYRINGES, TWO DIFFERENT
APPOINTMENTS, PPE.
ALL OF SUDDEN IT GETS EXPENSIVE
THAT YOU DOUBLED THE AMOUNT OF
SUPPLIES YOU NEED FOR THE
VACCINE.
ON TOP OF THAT IT REQUIRES VERY
SPECIFIC STORAGE.
IT HAS TO BE KEPT AT NEGATIVE
90 DEGREES FAHRENHEIT, BELOW
ZERO ESSENTIALLY.
STORING THE VACCINE IT
DIFFICULT.
IT WILL NOT BE ABLE TO BE STORED
AT A LOT OF PLACES THAT
TYPICALLY HOUSE VACCINES.
THESE ARE DETAILS THAT COME INTO
THE DISTRIBUTION AND THAT IS
CRUCIAL.
WE’VE BEEN INCREDIBLE HAVING
SOME COUPLES AT LATE-STAGE
CRITICAL TRIALS.
GETTING INTO THE NITTY-GRITTY
BUT MANUFACTURING S SAFETY BUT
GETTING IT TO ALL THE PEOPLE AS
WELL.
CONNELL: THAT IS THE CHALLENGE.
THAT IS WHERE THE
"OPERATION WARP SPEED" FROM THE
ADMINISTRATION COMES INTO PLAY
TRYING TO GET THIS VACCINE
ROLLED OUT AS EFFECTIVELY AN
EFFICIENTLY AS POSSIBLE.
IF ONE OF YOUR PATIENTS SAYS
UPON SEEING NEWS, ALL RIGHT,
WE’RE GETTING THERE, THIS IS
CERTAINLY PROGRESS, HOW LONG
UNTIL I HAVE MY NORMAL LIFE
BACK, WHAT WOULD YOU TELL THEM
TODAY?
>> SO I MEAN, HERE IS THE THING
THIS IS ALL PRELIMINARY DATA.
WE STILL DON’T KNOW HOW LONG THE
IMMUNITY LASTS.
THEY HAVE NOT BROKEN DOWN THE
DATA IN TERMS OF HOW IT AFFECTS
CERTAIN VULNERABLE POPULATIONS
SUCH AS THE ELDERLY AND THOSE
IMMUNOSUPPRESSED.
YOU KNOW THERE ARE SOME
QUESTIONS WE NEED SOME ANSWERS
TO.
JUST LIKE THE FLU VACCINE, SO
YOU CAN GET A FLU SHOT BUT YOU
STILL GET THE FLU.
THE GOOD THING ABOUT THE FLU
VACCINE IT DECREASES THE
SEVERITY OF THE INFECTION IF YOU
GET IT.
WE DON’T KNOW IF THE COVID
VACCINE DOES AS WELL.
WHEN IT COMES TO THE TIMELINE, I
WANT TO SEE MORE LITERATURE AND
DATA.
HOWEVER IT DOES LOOK LIKE FRONT
LINE WORKERS, HIGH-RISK PEOPLE
MAY BE ABLE TO HAVE VACCINE BY
LATE 2020, BUT PROBABLY MORE
LIKELY EARLY 2021.
I WOULD SAY FOR THE GENERAL
POPULATION I STILL THINK IT WILL
BE SPRING EARLY SUMMER, BEFORE
THESE ARE WIDELY AVAILABLE.
THE GOOD NEWS IT IS NOT JUST
PFIZER.
WE HAVE MANY COMPANIES.
WE’LL SEE DATA WITHIN THE NEXT
MONTH OR TWO.
WE’LL HAVE A LOT MORE CHOICE
MOVING FORWARD INTO 2021.
CONNELL: INTERESTING WHAT YOU
SAID ABOUT HOW EFFECTIVE IT
MIGHT BE TO GET THE FLU OR CAN
YOU STILL GET COVID A QUESTION
ABOUT THAT.
GO BACK TO MY ORIGINAL QUESTION
TO FOLLOW UP, WHAT IS ACTUALLY
MEANS TO BE 90% EFFECTIVE IN THE
TRIALS?
YOU PROBABLY ALREADY SAID THIS,
TO MAKE IT CLEAR ABOUT PEOPLE,
HOW EFFECTIVE IT IS OR WHAT THAT
ACTUALLY MEANS TO BE 90%
EFFECTIVE?
>> SO THAT MEANS IN 90% OF THE
PEOPLE THEY LOOKED AT THE DATA
ON IT PREVENTED THE COVID
INFECTION.
WHICH IS GREAT, THAT IS
SIGNIFICANTLY BETTER THAN WE SEE
WITH THE FLU SHOT BUT WHAT I
WANT TO IN THAT 10% THEY DIDN’T
PREVENT THE INFECTION IN, WAS
THAT INFECTION LESS SEVERE
BECAUSE THEY HAD THE VACCINE?
THEY HAVE NOT STATED THAT YET.
BECAUSE THE PEOPLE WHO DIDN’T
GET COVID, THEY DIDN’T HAVE
SEVERE SYMPTOMS.
MORE DATA NEEDS TO COME OUT
BEFORE WE SEE THE RESULTS F THEY
CAN PREVENT IT 90% OF THE TIME
AND 10% LESS SEVERITY, SLAM
DUNK.
SAFETY CONCERNS IS VITAL AND
VERY KEY TO THIS.
THIS IS ALL EXTREMELY OPTIMISTIC
MOVING FORWARD BUT WE STILL NEED
SOME MORE DATA BEFORE WE CAN SAY
FOR CERTAIN, TO ANSWER ALL THE
QUESTIONS WE MAY HAVE ABOUT IT.
CONNELL: YEAH.
OVERALL GREAT DAY FOR SCIENCE
AND HANNITY AT THE BOTTOM OF THE